News about Quality / GMP

Aurobindo Pharma Ltd gets 3 observations from USFDA for Unit 3 at Bachupally Village

Aurobindo Pharma Ltd gets 3 observations from USFDA for Unit 3 at Bachupally Village

Quality / GMP | 24/07/2023 | By Sudeep Soparkar |  4176

Lupin receives tentative approval from U.S. FDA for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets

Lupin receives tentative approval from U.S. FDA for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets

Quality / GMP | 24/07/2023 | By Sudeep Soparkar |  771

Dr. Reddy's Laboratories Limited's API facility at Srikakulam completes USFDA inspection successfully

Dr. Reddy's Laboratories Limited's API facility at Srikakulam completes USFDA inspection successfully

Quality / GMP | 20/07/2023 | By Sudeep Soparkar |  2921

US FDA Inspection at Aurobindo Pharma Ltd's Unit XIV, Anakapalli District, Andhra Pradesh

US FDA Inspection at Aurobindo Pharma Ltd's Unit XIV, Anakapalli District, Andhra Pradesh

Quality / GMP | 18/07/2023 | By Sudeep Soparkar |  753

Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP

Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP

Quality / GMP | 18/07/2023 | By Sudeep Soparkar |  683

Gland Pharma Limited - Conclusion of US FDA Inspection at Dundigal Facility, Hyderabad

Gland Pharma Limited - Conclusion of US FDA Inspection at Dundigal Facility, Hyderabad

Quality / GMP | 17/07/2023 | By Sudeep Soparkar |  1383

Lupin Receives EIR from U.S. FDA for its Pithampur Unit-2 Manufacturing Facility

Lupin Receives EIR from U.S. FDA for its Pithampur Unit-2 Manufacturing Facility

Quality / GMP | 13/07/2023 | By Sudeep Soparkar |  1167

USFDA inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad concludes with nil observations

USFDA inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad concludes with nil observations

Quality / GMP | 10/07/2023 | By Sudeep Soparkar |  1603

Zydus receives EIR from the USFDA for its SEZ 1 manufacturing facility at Pharmez, Ahmedabad

Zydus receives EIR from the USFDA for its SEZ 1 manufacturing facility at Pharmez, Ahmedabad

Quality / GMP | 06/07/2023 | By Sudeep Soparkar |  1614

Granules India Successfully Completes Two US FDA Audits in a Span of Two Weeks for its Vizag and Jeedimetla facilities with Zero Observations

Zero Observations indicate commitment to comply with best global standards

Quality / GMP | 06/07/2023 | By Sudeep Soparkar |  946